ADVERTISEMENT

Shilpa Medicare Gets U.S. FDA Import Alert For Formulations Unit In Jadcherla: ICICI Securities

Shilpa Medicare Gets U.S. FDA Import Alert For Formulations Unit In Jadcherla: ICICI Securities

A technician performing a test at Shilpa Medicare Ltd.’s Research and Development faciltiy. (image Company website)
A technician performing a test at Shilpa Medicare Ltd.’s Research and Development faciltiy. (image Company website)
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More